Vanderbilt Team Seeks Genetic, Molecular Factors Involved in Bariatric Surgery Impact | GenomeWeb

NEW YORK (GenomeWeb News) – Vanderbilt University researchers have received a $1.2 million grant to investigate the cellular, molecular, and genetic factors involved in metabolic and hormonal changes that are caused by bariatric surgery.

The Vanderbilt team received the National Institutes of Health funding to discover the causes for the "many metabolic and hormonal changes" that are the result of bariatric surgery, commonly used for treating obesity and type 2 diabetes, Vanderbilt said late last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.